Annual CFF
$3.92 M
-$94.90 K-2.36%
December 31, 2023
Summary
- As of February 8, 2025, ABVC annual cash flow from financing activities is $3.92 million, with the most recent change of -$94.90 thousand (-2.36%) on December 31, 2023.
- During the last 3 years, ABVC annual CFF has fallen by -$5.65 million (-59.04%).
- ABVC annual CFF is now -60.79% below its all-time high of $10.00 million, reached on December 31, 2021.
Performance
ABVC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$145.40 K
-$1.01 M-116.74%
September 30, 2024
Summary
- As of February 8, 2025, ABVC quarterly cash flow from financing activities is -$145.40 thousand, with the most recent change of -$1.01 million (-116.74%) on September 30, 2024.
- Over the past year, ABVC quarterly CFF has dropped by -$1.80 million (-108.78%).
- ABVC quarterly CFF is now -102.12% below its all-time high of $6.87 million, reached on December 31, 2020.
Performance
ABVC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$1.49 M
-$1.80 M-54.79%
September 30, 2024
Summary
- As of February 8, 2025, ABVC TTM cash flow from financing activities is $1.49 million, with the most recent change of -$1.80 million (-54.79%) on September 30, 2024.
- Over the past year, ABVC TTM CFF has dropped by -$2.09 million (-58.45%).
- ABVC TTM CFF is now -89.18% below its all-time high of $13.73 million, reached on June 30, 2022.
Performance
ABVC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ABVC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.4% | -108.8% | -58.5% |
| 3 y3 years | -59.0% | -102.5% | -88.2% |
| 5 y5 years | +560.9% | -102.5% | -88.2% |
ABVC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -60.8% | at low | -103.4% | +42.6% | -89.2% | at low |
| 5 y | 5-year | -60.8% | +26.9% | -102.1% | +42.6% | -89.2% | at low |
| alltime | all time | -60.8% | >+9999.0% | -102.1% | +94.5% | -89.2% | +9691.6% |
ABVC BioPharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$145.40 K(-116.7%) | $1.49 M(-54.8%) |
| Jun 2024 | - | $868.50 K(+28.4%) | $3.29 M(+37.7%) |
| Mar 2024 | - | $676.20 K(+673.7%) | $2.39 M(-39.1%) |
| Dec 2023 | $3.92 M(-2.4%) | $87.40 K(-94.7%) | $3.92 M(+9.5%) |
| Sep 2023 | - | $1.66 M(-5342.1%) | $3.58 M(+41.7%) |
| Jun 2023 | - | -$31.60 K(-101.4%) | $2.52 M(-59.4%) |
| Mar 2023 | - | $2.21 M(-970.5%) | $6.22 M(+55.0%) |
| Dec 2022 | $4.01 M(-59.8%) | -$253.50 K(-142.0%) | $4.01 M(-52.9%) |
| Sep 2022 | - | $603.50 K(-83.5%) | $8.52 M(-38.0%) |
| Jun 2022 | - | $3.66 M(>+9900.0%) | $13.73 M(+38.0%) |
| Mar 2022 | - | $0.00(-100.0%) | $9.95 M(-0.4%) |
| Dec 2021 | $10.00 M(+4.5%) | $4.25 M(-26.9%) | $10.00 M(-20.7%) |
| Sep 2021 | - | $5.82 M(-5072.2%) | $12.61 M(+74.2%) |
| Jun 2021 | - | -$117.00 K(-377.3%) | $7.24 M(-19.6%) |
| Mar 2021 | - | $42.20 K(-99.4%) | $9.00 M(-5.9%) |
| Dec 2020 | $9.57 M(+209.9%) | $6.87 M(+1448.1%) | $9.57 M(+189.7%) |
| Sep 2020 | - | $443.70 K(-73.0%) | $3.30 M(-8.5%) |
| Jun 2020 | - | $1.64 M(+169.4%) | $3.61 M(+55.4%) |
| Mar 2020 | - | $610.40 K(+1.0%) | $2.32 M(-24.7%) |
| Dec 2019 | $3.09 M(+420.7%) | $604.20 K(-19.6%) | $3.09 M(+28.2%) |
| Sep 2019 | - | $751.70 K(+110.1%) | $2.41 M(+59.3%) |
| Jun 2019 | - | $357.70 K(-74.0%) | $1.51 M(-6.5%) |
| Mar 2019 | - | $1.37 M(-1954.0%) | $1.62 M(+172.7%) |
| Dec 2018 | $593.00 K(-62.0%) | -$74.10 K(-48.9%) | $592.90 K(-11.1%) |
| Sep 2018 | - | -$144.90 K(-131.4%) | $667.00 K(-49.9%) |
| Jun 2018 | - | $462.20 K(+32.2%) | $1.33 M(+38.8%) |
| Mar 2018 | - | $349.70 K(-32.8%) | $959.70 K(-41.1%) |
| Dec 2017 | $1.56 M(-4.3%) | - | - |
| Sep 2017 | - | $520.00 K(+477.8%) | $1.63 M(+15.6%) |
| Sep 2017 | $1.63 M(-38.6%) | - | - |
| Jun 2017 | - | $90.00 K(-90.5%) | $1.41 M(-58.1%) |
| Mar 2017 | - | $950.00 K(+1257.1%) | $3.37 M(+39.1%) |
| Dec 2016 | - | $70.00 K(-76.7%) | $2.42 M(-8.8%) |
| Sep 2016 | $2.65 M(>+9900.0%) | $300.00 K(-85.3%) | $2.65 M(+12.7%) |
| Jun 2016 | - | $2.05 M(>+9900.0%) | $2.35 M(+667.6%) |
| Mar 2016 | - | $3200.00(-98.9%) | $306.60 K(+1.1%) |
| Dec 2015 | - | $303.40 K(>+9900.0%) | $303.40 K(>+9900.0%) |
| Sep 2015 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2013 | $25.00 K(-97.1%) | $0.00(0.0%) | $25.00 K(-64.1%) |
| Jun 2013 | - | $0.00(0.0%) | $69.70 K(-81.3%) |
| Mar 2013 | - | $0.00(-100.0%) | $373.10 K(-33.2%) |
| Dec 2012 | - | $25.00 K(-44.1%) | $558.20 K(-36.3%) |
| Sep 2012 | $876.30 K(-48.5%) | $44.70 K(-85.3%) | $876.30 K(-22.6%) |
| Jun 2012 | - | $303.40 K(+63.9%) | $1.13 M(-7.9%) |
| Mar 2012 | - | $185.10 K(-46.1%) | $1.23 M(-34.4%) |
| Dec 2011 | - | $343.10 K(+14.4%) | $1.87 M(+10.1%) |
| Sep 2011 | $1.70 M(+60.3%) | $300.00 K(-25.0%) | $1.70 M(+8.4%) |
| Jun 2011 | - | $400.00 K(-51.7%) | $1.57 M(+0.3%) |
| Mar 2011 | - | $828.90 K(+381.9%) | $1.56 M(+97.1%) |
| Dec 2010 | - | $172.00 K(+2.5%) | $793.80 K(-25.2%) |
| Sep 2010 | $1.06 M(+65.6%) | $167.80 K(-57.6%) | $1.06 M(-6.5%) |
| Jun 2010 | - | $395.50 K(+576.1%) | $1.14 M(+2.8%) |
| Mar 2010 | - | $58.50 K(-86.7%) | $1.10 M(-19.5%) |
| Dec 2009 | - | $439.60 K(+81.7%) | $1.37 M(+114.1%) |
| Sep 2009 | $641.10 K(-76.4%) | $241.90 K(-33.7%) | $641.10 K(-68.1%) |
| Jun 2009 | - | $365.00 K(+12.0%) | $2.01 M(+3.3%) |
| Mar 2009 | - | $326.00 K(-211.7%) | $1.94 M(-19.9%) |
| Dec 2008 | - | -$291.80 K(-118.1%) | $2.43 M(-10.7%) |
| Sep 2008 | $2.72 M(-5.0%) | $1.61 M(+436.7%) | $2.72 M(+145.3%) |
| Jun 2008 | - | $300.00 K(-62.9%) | $1.11 M(-11.7%) |
| Mar 2008 | - | $808.00 K(>+9900.0%) | $1.25 M(+181.0%) |
| Dec 2007 | - | $0.00(-100.0%) | $446.50 K(0.0%) |
| Sep 2007 | $2.86 M(>+9900.0%) | - | - |
| Jun 2007 | - | $446.50 K(>+9900.0%) | $446.50 K(>+9900.0%) |
| Mar 2007 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | -$2.64 M(-200.0%) | $0.00(-100.0%) |
| Sep 2006 | - | $2.64 M(>+9900.0%) | $2.64 M(>+9900.0%) |
| Jun 2006 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2006 | - | $0.00(0.0%) | -$3200.00(<-9900.0%) |
| Dec 2005 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2005 | - | -$3200.00(-200.0%) | $0.00(-100.0%) |
| Mar 2005 | - | $3200.00(>+9900.0%) | $3200.00(-120.6%) |
| Dec 2004 | -$15.50 K(-115.0%) | $0.00(0.0%) | -$15.50 K(0.0%) |
| Sep 2004 | - | $0.00(0.0%) | -$15.50 K(0.0%) |
| Jun 2004 | - | $0.00(-100.0%) | -$15.50 K(0.0%) |
| Mar 2004 | - | -$15.50 K | -$15.50 K |
| Dec 2003 | $103.20 K | - | - |
FAQ
- What is ABVC BioPharma annual cash flow from financing activities?
- What is the all time high annual CFF for ABVC BioPharma?
- What is ABVC BioPharma annual CFF year-on-year change?
- What is ABVC BioPharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ABVC BioPharma?
- What is ABVC BioPharma quarterly CFF year-on-year change?
- What is ABVC BioPharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for ABVC BioPharma?
- What is ABVC BioPharma TTM CFF year-on-year change?
What is ABVC BioPharma annual cash flow from financing activities?
The current annual CFF of ABVC is $3.92 M
What is the all time high annual CFF for ABVC BioPharma?
ABVC BioPharma all-time high annual cash flow from financing activities is $10.00 M
What is ABVC BioPharma annual CFF year-on-year change?
Over the past year, ABVC annual cash flow from financing activities has changed by -$94.90 K (-2.36%)
What is ABVC BioPharma quarterly cash flow from financing activities?
The current quarterly CFF of ABVC is -$145.40 K
What is the all time high quarterly CFF for ABVC BioPharma?
ABVC BioPharma all-time high quarterly cash flow from financing activities is $6.87 M
What is ABVC BioPharma quarterly CFF year-on-year change?
Over the past year, ABVC quarterly cash flow from financing activities has changed by -$1.80 M (-108.78%)
What is ABVC BioPharma TTM cash flow from financing activities?
The current TTM CFF of ABVC is $1.49 M
What is the all time high TTM CFF for ABVC BioPharma?
ABVC BioPharma all-time high TTM cash flow from financing activities is $13.73 M
What is ABVC BioPharma TTM CFF year-on-year change?
Over the past year, ABVC TTM cash flow from financing activities has changed by -$2.09 M (-58.45%)